Browse > Article
http://dx.doi.org/10.4062/biomolther.2021.064

Hair Growth Promotion by δ-Opioid Receptor Activation  

Zheng, Mei (STEMORE Co. Ltd.)
Choi, Nahyun (STEMORE Co. Ltd.)
Balboni, Gianfranco (Department of Life and Environment Sciences, University of Cagliari)
Xia, Ying (Shanghai Key Laboratory of Acupuncture Mechanism and Acupoint Function, Fudan University)
Sung, Jong-Hyuk (STEMORE Co. Ltd.)
Publication Information
Biomolecules & Therapeutics / v.29, no.6, 2021 , pp. 643-649 More about this Journal
Abstract
Literature has revealed that the delta opioid receptor (DOR) exhibited diverse pharmacological effects on neuron and skin. In the present study, we have investigated whether the activation of DOR has hair-growth promotion effects. Compared with other opioid receptor, DOR was highly expressed in epidermal component of hair follicle in human and rodents. The expression of DOR was high in the anagen phase, but it was low in the catagen and telogen phases during mouse hair cycle. Topical application of UFP-512, a specific DOR agonist, significantly accelerated the induction of the anagen in C3H mice. Topical application of UFP-512 also increased the hair length in hair organ cultures and promoted the proliferation and the migration of outer root sheath (ORS) cells. Similarly, pharmacological inhibition of DOR by naltrindole significantly inhibited the anagen transition process and decreased hair length in hair organ cultures. Thus, we further examined whether Wnt/β-catenin pathway was related to the effects of DOR on hair growth. We found that Wnt/β-catenin pathway was activated by UFP-512 and siRNA for β-catenin attenuated the UFP-512 induced proliferation and migration of ORS cells. Collectively, result established that DOR was involved in hair cycle regulation, and that DOR agonists such as UFP-512 should be developed for novel hair-loss treatment.
Keywords
${\delta}$-opioid receptor; UFP-512; Outer root sheath cells; Hair growth; Anagen; $Wnt/{\beta}-catenin$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chen, D., Jarrell, A., Guo, C., Lang, R. and Atit, R. (2012) Dermal betacatenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation. Development 139, 1522-1533.   DOI
2 Collins, C. A., Kretzschmar, K. and Watt, F. M. (2011) Reprogramming adult dermis to a neonatal state through epidermal activation of beta-catenin. Development 138, 5189-5199.   DOI
3 Bigliardi-Qi, M., Gaveriaux-Ruff, C., Zhou, H., Hell, C., Bady, P., Rufli, T., Kieffer, B. and Bigliardi, P. (2006) Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing. Differentiation 74, 174-185.   DOI
4 Neumann, C., Bigliardi-Qi, M., Widmann, C. and Bigliardi, P. L. (2015) The delta-opioid receptor affects epidermal homeostasis via ERK-dependent inhibition of transcription factor POU2F3. J. Invest. Dermatol. 135, 471-480.   DOI
5 Charbaji, N., Schafer-Korting, M. and Kuchler, S. (2012) Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation. PLoS ONE 7, e42616.   DOI
6 Fu, J. and Hsu, W. (2013) Epidermal Wnt controls hair follicle induction by orchestrating dynamic signaling crosstalk between the epidermis and dermis. J. Invest. Dermatol. 133, 890-898.   DOI
7 He, X., Sandhu, H. K., Yang, Y., Hua, F., Belser, N., Kim, D. H. and Xia, Y. (2013) Neuroprotection against hypoxia/ischemia: delta-opioid receptor-mediated cellular/molecular events. Cell. Mol. Life Sci. 70, 2291-2303.   DOI
8 Jindo, T., Tsuboi, R., Imai, R., Takamori, K., Rubin, J. S. and Ogawa, H. (1994) Hepatocyte growth factor/scatter factor stimulates hair growth of mouse vibrissae in organ culture. J. Invest. Dermatol. 103, 306-309.   DOI
9 Mabrouk, O. S., Marti, M., Salvadori, S. and Morari, M. (2009) The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway. Neuroscience 164, 360-369.   DOI
10 Zaki, P. A., Bilsky, E. J., Vanderah, T. W., Lai, J., Evans, C. J. and Porreca, F. (1996) Opioid receptor types and subtypes: the delta receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36, 379-401.   DOI
11 Polastron, J., Mur, M., Mazarguil, H., Puget, A., Meunier, J. C. and Jauzac, P. (1994) SK-N-BE: a human neuroblastoma cell line containing two subtypes of delta-opioid receptors. J. Neurochem. 62, 898-906.   DOI
12 Qiu, J., Chao, D., Sheng, S., Khiati, D., Zhou, X. and Xia, Y. (2019) Delta-opioid receptor-Nrf-2-mediated inhibition of inflammatory cytokines in neonatal hypoxic-ischemic encephalopathy. Mol. Neurobiol. 56, 5229-5240.   DOI
13 Sheng, S., Huang, J., Ren, Y., Zhi, F., Tian, X., Wen, G., Ding, G., Xia, T. C., Hua, F. and Xia, Y. (2018) Neuroprotection against hypoxic/ischemic injury: delta-opioid receptors and BDNF-TrkB pathway. Cell. Physiol. Biochem. 47, 302-315.   DOI
14 Wang, J., Zhu, G., Huang, L., Nie, T., Tao, K., Li, Y. and Gao, G. (2017) Morphine administration induces change in anxiety-related behavior via Wnt/beta-catenin signaling. Neurosci. Lett. 639, 199-206.   DOI
15 Furkert, J., Klug, U., Slominski, A., Eichmuller, S., Mehlis, B., Kertscher, U. and Paus, R. (1997) Identification and measurement of beta-endorphin levels in the skin during induced hair growth in mice. Biochim. Biophys. Acta 1336, 315-322.   DOI
16 Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G. and Birchmeier, W. (2001) Beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105, 533-545.   DOI
17 Ito, M., Yang, Z., Andl, T., Cui, C., Kim, N., Millar, S. E. and Cotsarelis, G. (2007) Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 447, 316-320.   DOI
18 Li, Y., Wang, J., Li, Z., Cheng, H., Zhang, Z., Luo, T., Zhang, X., Gao, G., Lu, H. and Li, L. (2019) Propoxyphene mediates oxyhemoglobin-induced injury in rat cortical neurons through up-regulation of active-beta-catenin. Front. Pharmacol. 10, 1616.   DOI
19 Kim, J. H., Park, S. G., Kim, W. K., Song, S. U. and Sung, J. H. (2015) Functional regulation of adipose-derived stem cells by PDGFD. Stem Cells 33, 542-556.   DOI
20 McLaughlin, P. J., Pothering, C. A., Immonen, J. A. and Zagon, I. S. (2011) Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats. Exp. Biol. Med. (Maywood) 236, 1122-1132.   DOI
21 Poonawala, T., Levay-Young, B. K., Hebbel, R. P. and Gupta, K. (2005) Opioids heal ischemic wounds in the rat. Wound Repair Regen. 13, 165-174.   DOI
22 Bigliardi, P. L., Dancik, Y., Neumann, C. and Bigliardi-Qi, M. (2016) Opioids and skin homeostasis, regeneration and ageing - what's the evidence? Exp. Dermatol. 25, 586-591.   DOI
23 Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804.   DOI
24 Tortelly, V. D., De Mattos, T., Fernandes, L. S. A., Nunes, B. E. M. and Melo, D. F. (2019) Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias? Dermatol. Online J. 25, 13030/qt6j45h81f.
25 Vergura, R., Balboni, G., Spagnolo, B., Gavioli, E., Lambert, D. G., McDonald, J., Trapella, C., Lazarus, L. H., Regoli, D., Guerrini, R., Salvadori, S. and Calo, G. (2008) Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29, 93-103.   DOI
26 Yang, Y., Zhi, F., He, X., Moore, M. L., Kang, X., Chao, D., Wang, R., Kim, D. H. and Xia, Y. (2012) Delta-opioid receptor activation and microRNA expression of the rat cortex in hypoxia. PLoS ONE 7, e51524.   DOI
27 Reyes, B. A., Vakharia, K., Ferraro, T. N., Levenson, R., Berrettini, W. H. and Van Bockstaele, E. J. (2012) Opiate agonist-induced redistribution of Wntless, a mu-opioid receptor interacting protein, in rat striatal neurons. Exp. Neurol. 233, 205-213.   DOI
28 Aguila, B., Coulbault, L., Boulouard, M., Leveille, F., Davis, A., Toth, G., Borsodi, A., Balboni, G., Salvadori, S., Jauzac, P. and Allouche, S. (2007) In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance. Br. J. Pharmacol. 152, 1312-1324.   DOI
29 Andl, T., Reddy, S. T., Gaddapara, T. and Millar, S. E. (2002) WNT signals are required for the initiation of hair follicle development. Dev. Cell 2, 643-653.   DOI
30 Bigliardi-Qi, M., Bigliardi, P. L., Eberle, A. N., Buchner, S. and Rufli, T. (2000) Beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J. Invest. Dermatol. 114, 527-532.   DOI
31 Bigliardi, P. L., Neumann, C., Teo, Y. L., Pant, A. and Bigliardi-Qi, M. (2015) Activation of the delta-opioid receptor promotes cutaneous wound healing by affecting keratinocyte intercellular adhesion and migration. Br. J. Pharmacol. 172, 501-514.   DOI
32 Cao, S., Chao, D., Zhou, H., Balboni, G. and Xia, Y. (2015) A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation. Br. J. Pharmacol. 172, 1869-1881.   DOI
33 Marie, N., Lecoq, I., Jauzac, P. and Allouche, S. (2003) Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists. J. Biol. Chem. 278, 22795-22804.   DOI